Keymed Biosciences Inc. (HKG:2162)
Hong Kong · Delayed Price · Currency is HKD 59.25
-0.25 (-0.42%)
May 28, 2026, 9:30 AM HKT
Keymed Biosciences Market Cap
Keymed Biosciences has a market cap or net worth of 17.53 billion as of May 27, 2026. Its market cap has increased by 36.78% in one year.
Market Cap
17.53B
Enterprise Value
16.27B
Revenue
797.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
59.25
Market Cap Chart
Since July 8, 2021, Keymed Biosciences's market cap has decreased from 18.43B to 17.53B, a decrease of -4.88%. That is a compound annual growth rate of -1.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 17.53B | 11.32% |
| Dec 31, 2025 | 15.75B | 84.90% |
| Dec 31, 2024 | 8.52B | -37.32% |
| Dec 29, 2023 | 13.59B | -4.15% |
| Dec 30, 2022 | 14.17B | 46.87% |
| Dec 31, 2021 | 9.65B | -47.63% |
| Jul 8, 2021 | 18.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genscript Biotech | 28.38B |
| InnoCare Pharma | 24.94B |
| Duality Biotherapeutics | 20.12B |
| Metis TechBio | 19.45B |
| TransThera Sciences (Nanjing) | 17.31B |
| Ascletis Pharma | 16.57B |
| Zai Lab | 16.38B |
| Ascentage Pharma Group International | 15.33B |